Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review-Reference-Cited by-同舟云学术

Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review

Published:2018-06-15 Issue:46 Volume:9 Page:28281-28289
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chae Young Kwang¹²,Chiec Lauren¹,Adney Scott K.¹,Waitzman Josh¹,Costa Ricardo³,Carneiro Benedito⁴,Matsangou Maria¹²,Agulnik Mark¹²,Kopp Peter¹,Giles Frank¹²

Affiliation:

1. Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

2. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA

3. H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA

4. Lifespan Cancer Institute, Providence, RI 02906, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posterior Reversible Encephalopathy Syndrome as an Adverse Effect of Lenvatinib in a Patient with Papillary Thyroid Carcinoma: A Case Report;International Journal of Endocrinology and Metabolism;2023-07-29

2. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma;Brain Sciences;2022-12-23

3. Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib;Immunotherapy;2022-11

4. Metastatic medullary thyroid carcinoma: a new way forward;Endocrine-Related Cancer;2022-07-01

5. Sunitinib-Induced Cutaneous Small-Vessel Vasculitis: A Rare Case Report;Journal of Skin and Stem Cell;2022-06-14